L-asparaginase inhibits invasive and angiogenic activity and induces autophagy in ovarian cancer

Journal of Cellular and Molecular Medicine

Volumn 16, Issue 10, 2012, Pages 2369-2378

  Yu, Minshu ^a   Henning, Ryan ^a   Walker, Amanda ^a   Kim, Geoffrey ^a   Perroy, Alyssa ^a   Alessandro, Riccardo ^b   Virador, Victoria ^a   Kohn, Elise C ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF PALERMO   (Italy)

Author keywords

Angiogenesis; Asparaginase; Autophagy; Ovarian cancer; Sialyl Lewis X

Indexed keywords

5 ACETYLNEURAMINYL (2 3) GALACTOSYL (1 4) (FUCOPYRANOSYL (1 3)) N ACETYLGLUCOSAMINE; 5-ACETYLNEURAMINYL-(2-3)-GALACTOSYL-(1-4)-(FUCOPYRANOSYL-(1-3))-N-ACETYLGLUCOSAMINE; ANGIOGENESIS INHIBITOR; ASPARAGINASE; BETA1 INTEGRIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; OLIGOSACCHARIDE;

ARTICLE; AUTOPHAGY; CELL ADHESION; CELL MEMBRANE; DRUG EFFECT; ENDOTHELIUM CELL; ENZYMOLOGY; FEMALE; GENETICS; GLYCOSYLATION; HUMAN; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); OVARY TUMOR; PATHOLOGY; TUMOR CELL LINE;

ANGIOGENESIS INHIBITORS; ANTIGENS, CD29; ASPARAGINASE; AUTOPHAGY; CELL ADHESION; CELL LINE, TUMOR; CELL-MATRIX JUNCTIONS; E-SELECTIN; ENDOTHELIAL CELLS; FEMALE; GLYCOSYLATION; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; OLIGOSACCHARIDES; OVARIAN NEOPLASMS;

EID: 84866763134     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2012.01547.x     Document Type: Article

References (54)

1. Ziche M, Alessandri G, Gullino PM. Gangliosides promote the angiogenic response. Lab Invest. 1989; 61: 629-34.
2. Passaniti A, Hart GW. Cell surface sialylation and tumour metastasis. Metastatic potential of B16 melanoma variants correlates with their relative numbers of specific penultimate oligosaccharide structures. J Biol Chem. 1988; 263: 7591-603.
3. Schirrmacher V. Cancer metastasis: experimental approaches, theoretical concepts, and impacts for treatment strategies. Adv Cancer Res. 1985; 43: 1-73.
4. Seales EC, Jurado GA, Brunson BA, et al. Hypersialylation of beta1 integrins, observed in colon adenocarcinoma, may contribute to cancer progression by up-regulating cell motility. Cancer Res. 2005; 65: 4645-52.
5. Morgenthaler J, Kemmner W, Brossmer R. Sialic acid dependent cell adhesion to collagen IV correlates with in vivo tumourigenicity of the human colon carcinoma sublines HCT116, HCT116a and HCT116b. Biochem Biophys Res Commun. 1990; 171: 860-6.
6. Tamada Y, Takeuchi H, Suzuki N, et al. Biological and therapeutic significance of MUC1 with sialoglycans in clear cell adenocarcinoma of the ovary. Cancer Sci. 2007; 98: 1586-91.
7. Matsushita Y, Nakamori S, Seftor EA, et al. Human colon carcinoma cells with increased invasive capacity obtained by selection for sialyl-dimeric LeX antigen. Exp Cell Res. 1991; 196: 20-5.
8. Bosmann HB, Kessel D. Inhibition of glycoprotein synthesis in L5178Y mouse leukaemic cells by L-asparaginase in vitro. Nature. 1970; 226: 850-1.
9. Kessel D, Bosmann HB. Effects of L-asparaginase on protein and glycoprotein synthesis. FEBS Lett. 1970; 10: 85-8.
10. Kessel D, Bosmann HB. L-asparaginase effects on intact murine leukemia cells and on isolated cell plasma membranes. Biochem Biophys Res Commun. 1972; 48: 35-40.
11. Iwamoto S, Mihara K, Downing JR, et al. Mesenchymal cells regulate the response of acute lymphoblastic leukemia cells to asparaginase. J Clin Invest. 2007; 117: 1049-57.
12. Lorenzi PL, Llamas J, Gunsior M, et al. Asparagine synthetase is a predictive biomarker of L-asparaginase activity in ovarian cancer cell lines. Mol Cancer Ther. 2008; 7: 3123-8.
13. Lorenzi PL, Reinhold WC, Rudelius M, et al. Asparagine synthetase as a causal, predictive biomarker for L-asparaginase activity in ovarian cancer cells. Mol Cancer Ther. 2006; 5: 2613-23.
14. Flugy AM, D'Amato M, Russo D, et al. E-selectin modulates the malignant properties of T84 colon carcinoma cells. Biochem Biophys Res Commun. 2002; 293: 1099-106.
15. Majuri ML, Mattila P, Renkonen R. Recombinant E-selectin-protein mediates tumour cell adhesion via sialyl-Le(a) and sialyl-Le(x). Biochem Biophys Res Commun. 1992; 182: 1376-82.
16. Nguyen M, Strubel NA, Bischoff J. A role for sialyl Lewis-X/A glycoconjugates in capillary morphogenesis. Nature. 1993; 365: 267-9.
17. Liotta LA, Kohn EC. The microenvironment of the tumour-host interface. Nature. 2001; 411: 375-9.
18. Burnier JV, Wang N, Michel RP, et al. Type IV collagen-initiated signals provide survival and growth cues required for liver metastasis. Oncogene. 2011; 30: 3766-83.
19. Frisch SM, Vuori K, Ruoslahti E, et al. Control of adhesion-dependent cell survival by focal adhesion kinase. J Cell Biol. 1996; 134: 793-9.
20. Seales EC, Jurado GA, Singhal A, et al. Ras oncogene directs expression of a differentially sialylated, functionally altered beta1 integrin. Oncogene. 2003; 22: 7137-45.
21. von Lampe B, Stallmach A, Riecken EO. Altered glycosylation of integrin adhesion molecules in colorectal cancer cells and decreased adhesion to the extracellular matrix. Gut. 1993; 34: 829-36.
22. Mitra SK, Schlaepfer DD. Integrin-regulated FAK-Src signaling in normal and cancer cells. Curr Opin Cell Biol. 2006; 18: 516-23.
23. Shen TL, Park AY, Alcaraz A, et al. Conditional knockout of focal adhesion kinase in endothelial cells reveals its role in angiogenesis and vascular development in late embryogenesis. J Cell Biol. 2005; 169: 941-52.
24. Zhao J, Guan JL. Signal transduction by focal adhesion kinase in cancer. Cancer Metastasis Rev. 2009; 28: 35-49.
25. Hood JD, Cheresh DA. Role of integrins in cell invasion and migration. Nat Rev Cancer. 2002; 2: 91-100.
26. Sheppard D. Endothelial integrins and angiogenesis: not so simple anymore. J Clin Invest. 2002; 110: 913-4.
27. Pochec E, Litynska A, Bubka M, et al. Characterization of the oligosaccharide component of alpha3beta1 integrin from human bladder carcinoma cell line T24 and its role in adhesion and migration. Eur J Cell Biol. 2006; 85: 47-57.
28. Pochec E, Litynska A, Amoresano A, et al. Glycosylation profile of integrin alpha 3 beta 1 changes with melanoma progression. Biochim Biophys Acta. 2003; 1643: 113-23.
29. Janik ME, Litynska A, Vereecken P. Cell migration-the role of integrin glycosylation. Biochim Biophys Acta. 2010;1800:545-55.
30. Janik ME, Przybylo M, Pochec E, et al. Effect of alpha3beta1 and alphavbeta3 integrin glycosylation on interaction of melanoma cells with vitronectin. Acta Biochim Pol. 2010; 57: 55-61.
31. Azad NS, Posadas EM, Kwitkowski V, et al. Combination targeted therapy with sorafenib and bevacizumab results in enhanced toxicity and antitumour activity. J Clin Oncol. 2008; 26: 3709-14.
32. Cannistra SA, Matulonis UA, Penson RT, et al. Phase II study of bevacizumab in patients with platinum-resistant ovarian cancer or peritoneal serous cancer. J Clin Oncol. 2007; 25: 5180-6.
33. Hussain MM, Kotz H, Minasian L, et al. A phase II trial of carboxyamido-triazole (CAI) in patients with relapsed epithelial ovarian cancer. J Clin Oncol. 2003; 21: 4356-63.
34. Kohn EC, Alessandro R, Spoonster J, et al. Angiogenesis: role of calcium-mediated signal transduction. Proc Natl Acad Sci USA. 1995; 92: 1307-11.
35. Kohn EC, Jacobs W, Kim YS, et al. Calcium influx modulates expression of matrix metalloproteinase-2 (72-kDa type IV collagenase, gelatinase A). J Biol Chem. 1994; 269: 21505-11.
36. D'Amato M, Flugy AM, Alaimo G, et al. Role of calcium in E-selectin induced phenotype of T84 colon carcinoma cells. Biochem Biophys Res Commun. 2003; 301: 907-14.
37. Virador V M., Davidson B, Czechowicz J, et al. The anti-apoptotic activity of BAG3 is restricted by caspases and the proteasome. PLoS One. 2009; 4: e5136.
38. Schaller MD, Hildebrand JD, Shannon JD, et al. Autophosphorylation of the focal adhesion kinase, pp125FAK, directs SH2-dependent binding of pp60src. Mol Cell Biol. 1994; 14: 1680-8.
39. Christie DR, Shaikh FM, Lucas JAI, et al. ST6Gal-I epression in ovarian cancer cells promotes an invasive phenotype by altering integrin glycosylation and function. J Ovarian Res. 2008; 1: 3.
40. Klionsky DJ, Emr SD. Autophagy as a regulated pathway of cellular degradation. Science. 2000; 290: 1717-20.
41. Levine B. Autophagy and cancer. Nature. 2007; 446: 745-7.
42. Levine B, Kroemer G. Autophagy in aging, disease and death: the true identity of a cell death impostor. Cell Death Differ. 2009; 16: 1-2.
43. Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011; 474: 609-15.
44. Gadhoum SZ, Sackstein R. CD15 expression in human myeloid cell differentiation is regulated by sialidase activity. Nat Chem Biol. 2008; 4: 751-7.
45. Skacel PO, Edwards AJ, Harrison CT, et al. Enzymic control of the expression of the X determinant (CD15) in human myeloid cells during maturation: the regulatory role of 6′-sialyltransferase. Blood. 1991; 78: 1452-60.
46. Molica S, Vacca A, Levato D, et al. Angiogenesis in acute and chronic lymphocytic leukemia. Leuk Res. 2004; 28: 321-4.
47. Lin S, Kemmner W, Grigull S, et al. Cell surface alpha 2, 6-sialylation affects adhesion of breast carcinoma cells. Exp Cell Res. 2002; 276: 101-10.
48. Hedlund M, Ng E, Varki A, et al. alpha 2-6 - linked sialic acids on n-glycans modulate carcinoma differentiation in vivo. Cancer Res. 2008; 68: 388-94.
49. Debnath J. Detachment-induced autophagy during anoikis and lumen formation in epithelial acini. Autophagy. 2008; 4: 351-3.
50. Lock R, Debnath J. Extracellular matrix regulation of autophagy. Curr Opin Cell Biol. 2008; 20: 583-8.
51. Levine B, Kroemer G. Autophagy in the pathogenesis of disease. Cell. 2008; 132: 27-42.
52. Ramakrishnan S, Nguyen TM, Subramanian IV, et al. Autophagy and angiogenesis inhibition. Autophagy. 2007; 3: 512-5.
53. Rouschop KM, Wouters BG. Regulation of autophagy through multiple independent hypoxic signaling pathways. Curr Mol Med. 2009; 9: 417-24.
54. Kaneko O, Gong L, Zhang J, et al. A binding domain on mesothelin for CA125/MUC16. J Biol Chem. 2009; 284: 3739-49.